In conclusion, our meta-analysis suggested that two functional polymorphisms of XRCC1, rs25487 and rs1799782, can be used as prognostic factors for platinum-based chemotherapy in Asian patients with NSCLC. The gene discussed is XRCC1; the disease is non-small cell lung carcinoma.